A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer

Condition:   Gastric Ulcer Interventions:   Drug: HIP0612;   Drug: HPP2202;   Drug: RLD2204;   Drug: HPP2201 Sponsor:   Hanmi Pharmaceutical Company Limited Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials